IAA Partners : MUSE Awards •
`
`Vega Digital Awards (https://vegaawards.com/)
`
`NYX Awards •
`
`TITAN Awards •
`
`New York Awards •
`
`LIT Awards •
`
`More Awards •
`
`LUMIFY(r) Redness Reliever Drops
`
`Helen & Gertrude
`
`Social Media - Product or Service Branding
`
`Bausch + Lomb
`
`United States
`
`Share:
`
`LUM I FY? is the first and only OTC eye drop developed with low-dose brimonidine tartrate for the
`treatment of ocular redness due to minor eye irritations. For both consumers and eye care
`professionals, our objective was to launch a brand new product to the highly regulated OTC
`market by utilizing key social platforms to maximize reach for the most efficient cost (CPM)
`well as to disrupt the currently stagnant eye redness reliever market.<br><br>We took the
`
`https://museaward.com/winner-info.php?id=2186
`
`Slayback Exhibit 1078, Page 1 of 14
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`Vega Digital Awards (https://vegaawards.com/)
`
`NYX Awards •
`
`TITAN Awards •
`
`New York Awards •
`
`LIT Awards •
`
`More Awards •
`
`LUMIFY(r) Redness Reliever Drops
`
`Helen & Gertrude
`
`Social Media - Product or Service Branding
`
`Bausch + Lomb
`
`United States
`
`Share:
`
`LUM I FY? is the first and only OTC eye drop developed with low-dose brimonidine tartrate for the
`treatment of ocular redness due to minor eye irritations. For both consumers and eye care
`professionals, our objective was to launch a brand new product to the highly regulated OTC
`market by utilizing key social platforms to maximize reach for the most efficient cost (CPM)
`well as to disrupt the currently stagnant eye redness reliever market.<br><br>We took the
`
`https://museaward.com/winner-info.php?id=2186
`
`Slayback Exhibit 1078, Page 1 of 14
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`overarching campaign and developed a unique tone and voice for social media that created
`awareness around this new product. As an added element, we had to speak to beauty mavens
`within the legal constraints of the eyecare health market, as well as work within the Facebook
`and lnstagram policies on showcasing before and after results. We wanted LUM I FY to be present
`in situations that fit within the beauty lifestyle (i.e., purse, gym bag, suitcase, bathroom vanity).
`<br><br>Among the results, a big win was that the Red Eye Category saw growth at an
`accelerated rate of +39.8%. LUMIFY grew to 27.5% at the end of January, 2019 from initial launch
`to take the #1 spot in the category!
`
`https://museaward.com/winner-info.php?id=2186
`
`Slayback Exhibit 1078, Page 2 of 14
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`https://museaward.com/winner-info.php?id=2186
`
`Slayback Exhibit 1078, Page 3 of 14
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`(https://museaward.com/upload/entry/winimg/rh3zwgjt.png)
`
`SE AS DIRECTED
`
`works in
`ONE MINUTE
`
`https://museaward.com/winner-info.php?id=2186
`
`Slayback Exhibit 1078, Page 4 of 14
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`Sterile
`
`0.25 FL OZ (7.5 ml)
`
`(https://museaward.com/upload/entry/winimg/uh00usq7.png)
`
`USE AS DIRECTED
`
`https://museaward.com/winner-info.php?id=2186
`
`Slayback Exhibit 1078, Page 5 of 14
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`(https://museaward.com/upload/entry/winimg/6gus2zj9.png)
`
`https://museaward.com/winner-info.php?id=2186
`
`Slayback Exhibit 1078, Page 6 of 14
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`(https://museaward.com/upload/entry/winimg/69afjvej.png)
`
`https://museaward.com/winner-info.php?id=2186
`
`Slayback Exhibit 1078, Page 7 of 14
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`look whiter
`and bri hter!''
`
`https://museaward.com/winner-info.php?id=2186
`
`Slayback Exhibit 1078, Page 8 of 14
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`-
`
`-Vincent Oquendo, Celebrity Makeup Artist
`
`(https://museaward.com/upload/entry/winimg/p836jnqv.jpg}
`
`Jill Duff & Deb Bawe
`
`Margo Tsallagova
`
`Becca Bellush & John Allen
`
`Erica Hickey
`
`Shaemus Spencer
`
`Haley Giangreco
`
`Kirsten VandenBout
`
`More Rose Gold Winners
`
`< Back to Winner Gallery (winner.php)
`
`2019
`
`https://museaward.com/winner-info.php?id=2186
`
`Slayback Exhibit 1078, Page 9 of 14
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`(winner-info.php?id=2252)
`
`Coastal Fellowship Church
`Coastal Fellowship Church (winner-info.php?id=2252)
`
`Coastal Fellowship Church
`
`Corporate Identity - Logos
`
`United States
`
`2019
`
`https://museaward.com/winner-info.php?id=2186
`
`Slayback Exhibit 1078, Page 10 of 14
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`(winner-info.php?id=2068)
`
`N/A
`Tarrant County College Website (winner-info.php?id=2068)
`
`Tarrant County College
`
`Website - Education
`
`United States
`
`2019
`
`~{f)(G)\
`~~ada
`/TCC¢il1aegie~tCountyCc
`
`https://museaward.com/winner-info.php?id=2186
`
`Slayback Exhibit 1078, Page 11 of 14
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`(winner-info.php?id=1968)
`
`Michael Loo Gim Hwei
`Showreel (winner-info.php?id=1968)
`
`Raffles College of Higher Education Pte Ltd
`
`Student Submission - Student Video
`
`Singapore
`
`2019
`
`~~ /tienrftu~~t'iyllieeienny)
`
`American Society for Yad Vashem
`
`https://museaward.com/winner-info.php?id=2186
`
`Slayback Exhibit 1078, Page 12 of 14
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`THE ZBOROWSKl'S {winner-info.php?id=2150)
`
`://www.
`
`Multipleoutlet Productions
`
`Video - Other Videos
`
`United States
`
`AUTHORl~ED
`AFFILIATE
`
`(https://clk.tradedoubler.com/click?p=264355&a=2970876&
`
`9=23440228)
`
`@ {https://youtube.com/c/Museawards) 0 {https://facebook.com/museaward)
`
`@ {https://twitter.com/museaward) @ {https://instagram.com/museaward/)
`
`https://museaward.com/winner-info.php?id=2186
`
`Slayback Exhibit 1078, Page 13 of 14
`Slayback v. Eye Therapies - IPR2022-00142
`
`
`
`Copyright © 2022 MUSE Creative Awards.
`All rights reserved. Use of this website signifies your agreement to the Terms of Use, Privacy Policy (content.php?pg=privacy), and use of cookies.
`Sponsored by International Awards Associate Inc. (https://iaaawards.org)
`
`https://museaward.com/winner-info.php?id=2186
`
`Slayback Exhibit 1078, Page 14 of 14
`Slayback v. Eye Therapies - IPR2022-00142
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
